Oleksandr Usyks Controversial TKO Victory Over Rico Verhoeven Potential Financial and Industry Fallout
Singapore Regulator Seeks Faster Onboarding for Private Banking Clients
Brigade Enterprises Expands Hyderabad Presence with Rs 850 Crore Residential Project in Kompally
Global Hiring Firm CEO Declares End of Traditional Office Jobs as Trades Surge
US Secretary of State Rubio Meets Indias Modi to Strengthen Energy Ties Amid Iran Supply Disruptions
Zscaler Doubles Down on AI Security with Symmetry Systems Acquisition Valuation Concerns Persist
DGXX Q3 2025 Earnings Net Loss Reported Amidst Market Volatility
KB Home Q1 2026 Earnings Modest EPS Beat Amid Stabilizing Housing Market
DOO Q1 2026 Earnings EPS Beat Sparks Positive Market Reaction
Hilltop Holdings Inc Q1 2026 Earnings EPS Beat Surprises Analysts by 30
Healthpeak Properties DOC Q1 2026 Earnings Massive EPS Surprise of 515 Driven by Strong Operations
AGNCP Q1 2026 Earnings Preferred Shares Benefit as EPS Exceeds Estimates by 145
Four Corners Property Trust FCPT Falls 14 as REIT Sector Pressures Intensify
W P Carey Inc WPC Mild Gain as REIT Tests Key Support Levels
Permian Resources Holds Steady After Minor Decline Key Levels in Focus
Rain Enhancement Technologies Warrants RAINW Trade Flat Near Key Resistance at 020
Heritage Commerce Corp HTBK Holds Steady at 1345 as Trading Remains RangeBound
TakeTwo Reaffirms GTA VI November Launch Despite Weaker Annual Bookings Forecast
ADXN Q1 2024 Earnings ClinicalStage Biotech Reports Net Loss as Pipeline Advances
Cohen Steers Infrastructure Fund UTF Holds Steady Near Resistance as Sector Dynamics Shift
LAUR Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher
PASG Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Reaction
OXLCO Q4 2025 Earnings EPS Misses Estimates Stock Remains Flat
SIMO Q1 2026 Earnings Strong EPS Beat Drives Share Price Higher
SJ Q1 2025 Earnings Loss Per Share Reported Amidst Positive Stock Reaction
FFBC Q1 2026 Earnings Earnings Beat Bolsters Investor Confidence
DMAC Q1 2026 Earnings WiderthanExpected Loss as Clinical Pipeline Advances